Pharma

Your Article Summary

See Latest Articles

Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit
Watson Pharmaceuticals, 07/30/09

Watson Pharmaceuticals, Inc. , a leader in generic and specialty branded pharmaceuticals, announced a license agreement with GeneraMedix, Inc., for the exclusive US marketing rights to a generic version of Ferrlecit, a drug indicated for the treatment of iron deficiency anemia in hemodialysis patients receiving supplemental epoetin therapy.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09

MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09

GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
GlaxoSmithKline, 12/18/09

 See all of M&A/Partnerships